We want to make sure you feel informed and comfortable throughout every step of your care
Explore frequently asked questions on this page, and remember that we are just a phone call away if you have additional questions or concerns.
Some common reasons any patient would not be treated with FLA are: patient can’t go into an MRI because of incompatible implants or hardware; we can’t see the tumor on MRI; the tumor is spread beyond the prostate; there are too many clinically-significant cancerous lesions (more than 2); the tumors are so large that treating the whole gland makes more sense. There are more reasons, but they tend to be specific to patient situations.
Yes, a biopsy is necessary because not all suspicious lesions detected in the prostate by MRI are cancer. Published studies indicate 40-60% of suspicious lesions in MRI are cancer, whereas the rest may represent other causes such as inflammation from a recent infection. We need to make sure the lesion we are treating is truly cancer and not risk treating a “look-alike” and leaving the real tumor cells behind.
We do administer IV antibiotics, prior to procedure for both the biopsy and the ablation. This best practice follows the consensus, outlined in Guidelines for Adult Antibiotic Prophylaxis in IR Procedure JVIR November 2010.
No, we do not perform a fusion biopsy. Our biopsy is done inside the MRI scanner and is more accurate than performing an ultrasound and fusing it with the MRI images
Scarring should not be an issue for us. Sometimes there is some blood clot (hematoma) left in the prostate gland after biopsies that can make it look different on MRI. That can affect the ability to detect cancer in a diagnostic scan, but is not really an issue for scans done during MRI guided biopsy or ablation, where we already know where it is located.
FLA can help reduce symptoms of BPH (benign prostate hypertrophy) but it is not immediate. In fact, immediately it might make it a little worse because of inflammation from the procedure that may cause temporary swelling. Some patients (quarter to a third) may require a temporary urinary catheter if the swelling prevents them from urinating. This should go away in a few days. The relief of prostate hypertrophy symptoms can be seen gradually over the course of several months, which was noted anecdotally in these cases.
Endorectal coils could be part of diagnostic MRI’s of the prostate, but not used in MR guided biopsies or focal laser ablations. The treatment cannot have an endorectal coil because the targeting system and needles have to go via their own rectal probe. There would be no room for both the coil and our procedure apparatus.